Search hospitals > Maryland > Baltimore
Johns Hopkins University/Sidney Kimmel Cancer Center
Claim this profileBaltimore, Maryland 21205
Global Leader in Cancer
Global Leader in Leukemia
Conducts research for Lymphoma
Conducts research for Tumors
Conducts research for Recurrence
1104 reported clinical trials
85 medical researchers
Summary
Johns Hopkins University/Sidney Kimmel Cancer Center is a medical facility located in Baltimore, Maryland. This center is recognized for care of Cancer, Leukemia, Lymphoma, Tumors, Recurrence and other specialties. Johns Hopkins University/Sidney Kimmel Cancer Center is involved with conducting 1,104 clinical trials across 788 conditions. There are 85 research doctors associated with this hospital, such as Kenneth J. Cohen, Nilofer S. Azad, Michael J. Pishvaian, and Channing Paller, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Leukemia
Global LeaderPhiladelphia chromosome positive
HLA negative
RB1 positive
Top PIs
Kenneth J. CohenJohns Hopkins University/Sidney Kimmel Cancer Center6 years of reported clinical research
Expert in Brain Tumor
Expert in Recurrence
49 reported clinical trials
94 drugs studied
Nilofer S. AzadJohns Hopkins University/Sidney Kimmel Cancer Center6 years of reported clinical research
Studies Bile Duct Cancer
Studies Cancer
13 reported clinical trials
26 drugs studied
Michael J. PishvaianSibley Memorial Hospital3 years of reported clinical research
Studies Pancreatic Cancer
Studies Tumors
14 reported clinical trials
34 drugs studied
Channing Paller, MDSibley Memorial Hospital5 years of reported clinical research
Expert in Prostate Cancer
Studies Cancer
12 reported clinical trials
24 drugs studied
Clinical Trials running at Johns Hopkins University/Sidney Kimmel Cancer Center
Breast Cancer
Prostate Cancer
Cancer
Non-Small Cell Lung Cancer
Lymphoma
Acute Lymphoblastic Leukemia
Lung Cancer
Tumors
Leukemia
Ovarian Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Omitting Radiation Therapy
for Breast Cancer
This study is evaluating whether a type of radiation therapy may help prevent breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Cancer Vaccine
for Triple Negative Breast Cancer
This phase II trial studies the effect of DNA plasmid based vaccine (STEMVAC) in treating patients with patients with stage IB-III triple negative breast cancer. STEMVAC may wake up the immune system in patients who have had a diagnosis of triple negative breast cancer and have been treated. STEMVAC targets proteins that are expressed on breast cancer cells and works by boosting the immune system to recognize and destroy the invader cancer cell proteins that are causing the disease. The purpose of this trial is to test the immune system's response to STEMVAC.
Recruiting2 awards Phase 218 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Johns Hopkins University/Sidney Kimmel Cancer Center?
Johns Hopkins University/Sidney Kimmel Cancer Center is a medical facility located in Baltimore, Maryland. This center is recognized for care of Cancer, Leukemia, Lymphoma, Tumors, Recurrence and other specialties. Johns Hopkins University/Sidney Kimmel Cancer Center is involved with conducting 1,104 clinical trials across 788 conditions. There are 85 research doctors associated with this hospital, such as Kenneth J. Cohen, Nilofer S. Azad, Michael J. Pishvaian, and Channing Paller, MD.
Where is Johns Hopkins University/Sidney Kimmel Cancer Center located?
The Johns Hopkins Kimmel Cancer Center is situated in the Weinberg Building on Broadway Street, Baltimore, MD. For access, proceed on Broadway, then turn right onto Jefferson Street after Orleans Street.
Who should I call to ask about financial aid or insurance network?
**Johns Hopkins University/Sidney Kimmel Cancer Center Contact Information:**
**Financial Assistance:**
- Medical Oncology: 410-502-1304 or 410-955-8995
- Radiation Oncology: 410-614-1358 or 410-502-1643
**Student Financial Support:**
- Undergraduate Students: 410-516-8028
- Graduate Students: Visit the SEAM contact page for a dedicated adviser.
What insurance does Johns Hopkins University/Sidney Kimmel Cancer Center accept?
The Johns Hopkins University/Sidney Kimmel Cancer Center accepts a variety of insurance plans, such as Aetna, CareFirst BlueCross BlueShield, Cigna Healthcare, and UnitedHealthcare, among others. Coverage may vary based on insurance product type, employer benefit design, and physician location or specialty, so it's crucial to contact the insurer directly to confirm. Most Johns Hopkins Medicine hospitals and physicians participate with Medicare Advantage Plans, but patients should verify if an authorization and/or referral is necessary for services at specific facilities.
What awards or recognition has Johns Hopkins University/Sidney Kimmel Cancer Center received?
Johns Hopkins University's Sidney Kimmel Comprehensive Cancer Center, located in Baltimore, Maryland, was renamed in honor of philanthropist Sidney Kimmel following his $150 million donation for cancer research and patient care. The center is celebrated for its pioneering surgical treatments and extensive research in areas such as the genetic basis of colon cancer, cancer pain treatment, gene therapy, and innovative therapies for breast cancer. It has also gained acclaim for its researchers being named to the National Academy of Inventors, underscoring their significant contributions to science and society.